Science
Mechanism of Action
The skincare efficacy of Haematoxylum campechianum Powder is primarily attributed to haematoxylin and associated homoisoflavonoids. These compounds exhibit anti-inflammatory properties by inhibiting protein tyrosine kinases, crucial mediators in inflammatory responses. Additionally, research suggests its capacity to reduce melanin production, indicating a potential skin-brightening effect, and it functions as both an astringent and an antimicrobial agent.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
The chromophoric components are highly sensitive to pH, causing color shifts from yellowish-red in acidic conditions to brown at neutral pH, and purple in alkaline environments.
Conflicts
- Formulations containing metal ions (e.g., iron, alum, copper) may experience color changes due to reactions with the extract.
Safety
Safety Profile
Comprehensive safety assessments for oral, parenteral, dermal, and inhalation toxicity are currently 'not determined'. However, GHS classifications have not identified specific hazards. The FDA has approved logwood extract, from Haematoxylum campechianum, as a color additive under Sec. 73.1410. General handling precautions for powders are advised.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While exhibiting promising mechanisms for skin benefits, the current research lacks comprehensive clinical efficacy data and detailed safety assessments to establish its precise value in advanced skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…